Jianfei Qian, PhD

Jianfei Qian received both his DVM and PhD in China. In 2002, he came to the US as a postdoctoral research fellow in Dr. Qing Yi’s lab at the University of Arkansas for Medical Sciences. In 2018, he was recruited as an assistant research professor at The Houston Methodist Research Institute. His research is focused on the development of novel immunotherapy methods to treat multiple myeloma (MM) and other cancers by using anti-tumor-specific monoclonal antibodies (mAbs), identifying new cancer-specific antigens, and developing novel tumor vaccines.

Xingzhe Ma, PhD

Xingzhe Ma received her PhD in biochemistry and molecular biology at Nankai University in China. After graduation, she joined Dr. Qing Yi’s lab as a postdoctoral research fellow in 2015, and promoted to research associate in 2019. She works in the field of immunometabolism and cancer immunotherapy.

Pan Su, PhD

Pan Su received his PhD in Shanghai Institute of Biochemistry and Cell Biology, China Academy of Science where he focused on the regulation of autoimmune responses and autoimmune diseases, like Multiple sclerosis and Asthma. He joined the Yi lab in November 2016, working on the tumor biology project. His research mainly focuses on determining the mechanisms about the regulatory role of tumor microenvironment and tumor associated-macrophages (TAMs) during the development, progression, and drug resistance in multiple myeloma. He also focuses on the tumor immunotherapy and the regulation of anti-tumor effect of T cells in tumor microenvironment. Pan Su enjoys some outdoor activities, fishing, traveling and reading in his spare time.

Qiang Wang, PhD

Qiang Wang received his PhD in Microbiology at University of Chinese Academy of Science where he focused on molecular mechanisms of Influenza A virus replication. During his postdoctoral training at Lerner Research Institute of Cleveland Clinic, Wang developed a series of experimental methods to investigate the cross-talk between the tumor microenvironment and multiple myeloma. He has broad interests in the regulation of myeloma intrinsic and extrinsic drug resistance. In his free time, he enjoys outdoor activities with his family, watching movies, and playing basketballs.

Zhou Wang, PhD

Zhou Wang graduated from Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China in 2014 and their current projects are focused on the tumorigenesis mechanisms about MM and related therapeutic treatments against it.

Miao Xian, PhD

Miao Xian received her PhD in tumor pharmacology at Zhejiang University where she studied treatment of osteosarcoma and post translational modification of proteins. She joined Yi Lab in October 2019, working on tumor biology of multiple myeloma. Her research focuses on the role of bone marrow microenvironment in multiple myeloma. Miao enjoys go to concerts and music festivals in her free time.

Liuling Xiao, PhD

Luiling graduated from Fudan University, Shanghai, China in 2017, and started the postdoctoral fellow training from September, 2017. My present project focuses on exploring the role of CD8+ T cells in the melanoma and multiple myeloma

Lingqun Ye, PhD

Lingqun received a Ph.D. degree in Genetics from Chinese Academy of Sciences. He got Bachelor’s degree in Computer Science and worked as a Software Engineer for 5 years. He is interested in developing bioinformatics tools and using these tools to enhance cancer research.